
J Neuropsychiatry Clin Neurosci 21:68-74, Winter
doi: 10.1176/appi.neuropsych.21.1.68
© 2009 American Neuropsychiatric Association
Amount of HIV DNA in Peripheral Blood Mononuclear Cells is Proportional to the Severity of HIV-1-Associated Neurocognitive Disorders
Bruce Shiramizu, M.D.,
Andrew E. Williams, Ph.D.,
Cecilia Shikuma, M.D. and
Victor Valcour, M.D.
Received June 14, 2007; revised October 13, 2007; accepted February 6, 2008. Drs. Shiramizu, Shikuma, and Valcour are affiliated with the Hawaii AIDS Clinical Research Program, University of Hawaii, Honolulu; Dr. Williams is affiliated with Kaiser Foundation Hospitals, Center for Health Research, Honolulu. Address correspondence to Bruce Shiramizu, 3675 Kilauea Ave., Young Building, 5th Floor, Honolulu, HI 96816; bshirami{at}hawaii.edu (e-mail).
Human immunodeficiency virus (HIV) DNA in peripheral blood mononuclear cells was previously associated with neuropsychological function. By including individuals encompassing the full range of HIV-1-associated neurocognitive disorders, this study reports results from subjects with normal cognition, minor cognitive motor disorder, and HIV-1-associated dementia. Individuals with normal cognition had relatively low HIV DNA levels compared to those with minor cognitive motor disorder and HIV-1-associated dementia. Neuropsychological deficits were significantly associated with entry HIV DNA in all domains. These findings demonstrate for the first time that the severity of HIV-1-associated neurocognitive disorders is proportional to the amount of circulating HIV DNA.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2009
American Neuropsychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|